New Study Aims to Predict Infection Risk in Infants With Gastroschisis

Infants born with gastroschisis face one of the most visually striking and clinically demanding challenges in neonatal medicine. In this congenital abdominal wall defect, the infant’s intestines protrude through an opening beside the umbilicus and develop without the protective covering of a membrane, exposing delicate bowel tissue to amniotic fluid before birth and to the open air of the delivery room afterward. Surgeons typically work quickly to return the organs to the abdominal cavity, whether in a single primary closure or through a staged process using a silastic silo that gradually eases the bowel back inside over several days. Yet the operation itself is only the beginning of a long and fragile recovery, and one complication looms larger than almost any other in the weeks that follow: infection.

A new study published in the Journal of Perinatology turns its attention to precisely this problem, asking whether clinicians can identify, early in a hospital stay, which infants with gastroschisis are most likely to develop serious infections. The research, available at https://doi.org/10.1038/s41372-026-02880-x, reflects a broader movement in neonatology toward risk prediction models that move care away from a one-size-fits-all approach and toward individualized surveillance. For a condition as variable as gastroschisis, where two infants of similar birth weight can follow dramatically different clinical courses, the ability to stratify risk at the bedside could reshape how intensively each baby is monitored and how quickly clinicians respond to subtle warning signs.

The clinical stakes are considerable. Neonates with gastroschisis are routinely exposed to a dense constellation of infection risks. Central venous catheters, which are essential for delivering parenteral nutrition while the injured bowel recovers its function, are a well-established gateway for bloodstream infections. Prolonged fasting leaves the gut barrier compromised. Repeated operations, open abdominal wounds, and lengthy intensive care stays each add further opportunities for bacterial colonization and invasion. Inflammatory responses triggered by the exposed bowel itself can blur the line between expected postoperative inflammation and the earliest signs of sepsis, making diagnosis notoriously difficult in this population.

This diagnostic ambiguity is one of the central reasons why predictive modeling has become such an active frontier in neonatal research. In a typical newborn, fever, lethargy, and abnormal blood counts prompt a sepsis evaluation and often empiric antibiotics. In an infant recovering from gastroschisis repair, however, many of those same signals can arise from the surgical insult or from the impaired gut motility that almost universally follows. C-reactive protein levels, white blood cell counts, and platelet trends all shift in the days after abdominal surgery for reasons that have nothing to do with infection. Clinicians therefore walk a narrow line: treat too aggressively, and the infant faces the well-documented harms of unnecessary antibiotics, including disrupted microbiome development, fungal overgrowth, and selection for resistant organisms; treat too cautiously, and a true bloodstream infection can progress to septic shock with devastating speed.

Predictive tools attempt to resolve this tension by combining multiple clinical variables into a single, quantified estimate of risk. In the context of gastroschisis, such variables typically include gestational age at delivery, birth weight, the presence and severity of bowel complications such as atresia or volvulus, the type of abdominal closure achieved, the duration of mechanical ventilation, the length of time central catheters remain in place, and the interval before enteral feeding is tolerated. Laboratory markers, including serial inflammatory indices and culture results, add another layer of information. When these inputs are weighted appropriately, they can distinguish, with meaningful statistical separation, between infants whose postoperative course is following an expected trajectory and those whose trajectory has quietly diverged toward infection.

The methodology behind such models is as important as the models themselves. Robust prediction research requires large, well-characterized cohorts, careful handling of missing data, and honest internal and external validation. A model that performs impressively in the dataset used to build it but fails when applied to a different hospital’s population is of little clinical value, a phenomenon researchers call overfitting. Modern approaches increasingly incorporate penalized regression techniques, which constrain model complexity to improve generalizability, and some groups have begun exploring machine learning classifiers that can capture nonlinear interactions among variables. Whatever the statistical engine, the output must ultimately be interpretable at the bedside: a neonatologist at three in the morning needs a number, a trend, and a clear sense of what action that number should prompt.

For infants with gastroschisis, the practical payoff of reliable risk prediction would extend across the entire care pathway. Infants flagged as high risk could be prioritized for earlier and more frequent laboratory surveillance, stricter catheter hygiene protocols, or prophylactic strategies that are currently reserved for the most vulnerable patients. Nursing teams could adjust monitoring intervals, and antimicrobial stewardship programs could use risk scores to decide when empiric therapy is justified and when watchful waiting is safe. Conversely, infants identified as low risk could potentially avoid some of the cascades of testing and treatment that prolong intensive care stays and expose newborns to unnecessary interventions. In an era when neonatal units are under constant pressure to improve outcomes while reducing iatrogenic harm, this kind of stratification is exactly the kind of tool that translates epidemiological insight into bedside benefit.

The study also arrives at a moment of genuine progress in gastroschisis outcomes overall. Survival for isolated gastroschisis in high-resource settings now exceeds ninety percent, and the majority of infants go on to normal growth and development. But morbidity remains stubbornly high, and infection is consistently among the leading drivers of prolonged hospitalization, repeated imaging, extended parenteral nutrition, and delayed discharge. Every week of hospitalization carries costs, both financial and developmental, since prolonged neonatal intensive care separates infants from their families during a critical window of bonding and neurodevelopment. Reducing infection-related morbidity is therefore not merely a matter of preventing acute crises; it is a lever for shortening stays, accelerating family-centered care, and improving the long-term trajectory of these children.

There are, of course, important caveats that temper enthusiasm. Prediction is not prevention. A risk score, however accurate, does not by itself lower infection rates; it must be coupled to interventions that change management, and those interventions must themselves be proven effective in this specific population. Questions of equity also deserve attention, since models trained on data from a small number of centers may perform differently across diverse populations, and gastroschisis incidence varies notably by maternal age and socioeconomic factors, with the condition occurring more frequently in younger mothers. Any predictive tool intended for broad clinical use will need validation across geographically and demographically varied cohorts before it can be trusted to guide care universally.

Still, the direction of travel is clear. Neonatology is steadily accumulating the large, granular datasets needed to build dependable prognostic instruments, and gastroschisis, with its well-defined population and its concentrated period of high risk, is an ideal candidate for this kind of precision approach. The Journal of Perinatology study adds to a growing evidence base suggesting that the complications of congenital surgical conditions need not be met with reactive medicine alone. If clinicians can reliably forecast which infants are sliding toward infection before the first positive culture returns, the window for effective intervention opens days earlier, and days matter enormously in the life of a newborn. For the families who spend anxious weeks at the incubator’s side, and for the clinicians who care for them, that earlier warning could make the difference between a complication and a catastrophe, between a prolonged stay and a safe journey home.

Subject of Research: Predicting infection risk in infants with gastroschisis

Article Title: Predicting risk of infection in infants with gastroschisis

Article References: Predicting risk of infection in infants with gastroschisis. (n.d.). https://doi.org/10.1038/s41372-026-02880-x

Image Credits: AI Generated

DOI: 10.1038/s41372-026-02880-x

Keywords: gastroschisis, neonatal infection, risk prediction, Journal of Perinatology, neonatal intensive care, sepsis, abdominal wall defect, central venous catheter, antimicrobial stewardship, predictive modeling, newborn surgery, neonatal outcomes